Delivery Order SPE2DB24D1007-SPE2DB25FCCXR
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Droxidopa 100 mg capsules (90-count units) at a ceiling value of $1,266.73. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion by August 18, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4,563,988,174 units of the pharmaceutical drug Droxidopa 100 mg capsule. The contract has a ceiling value of $9,909.13 and a period of performance through March 18, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential...
- This federal contract award, valued at $7,207.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of droxidopa 100 mg capsules, a medication used to treat certain neurological conditions. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,091,994 units of the prescription medication Droxidopa 100 mg capsules in 90-count packages. The contract has a ceiling value of $5,948.85 and a period of performance ending on May 1, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition....
- This federal contract award, with ID SPE2DX15D1053|SPE2DX25F6MVR, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 200 mg Droxidopa capsules. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $22,532.79 and a performance period through April 30, 2025. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC)...
- This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 90-count capsules of the medication droxidopa 300 mg, with a total ceiling value of $34,269.58 and an ultimate completion date of July 11, 2025. This contract is not set aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,721.40 firm fixed price delivery order contract is for the supply of DROXIDOPA 100 MG CAPSULE 90S, a pharmaceutical product, with a period of performance through February 26, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide DROXIDOPA 100 MG CAPSULE 90S. The contract has a firm fixed price, with a ceiling value of $1,336.75, and an ultimate completion date of July 10, 2025. This delivery order is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp is a significant federal contractor, holding a $999,999,999.00 Indefinite...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of DROXIDOPA 100 MG CAPSULE 90S, a pharmaceutical product, with a ceiling value of $37,579.10 and a performance period through March 22, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through...
- This federal contract award, identified as SPE2DB25D3018|SPE2DB25FUXMP, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,236,364 units of DROXIDOPA 300 MG CAPSULE 90S, a medication, with a ceiling value of $28,310.61. The contract is a firm fixed-price arrangement with a period of performance extending to May 14, 2025. Amerisourcebergen...
- SPE2DB24D1007Indefinite Delivery Contract
- SPE2DB24D1007-SPE2DB25FCCXRDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Droxidopa 200 mg capsules (90-count units) valued at $25,920.22. This firm fixed-price delivery order, awarded on August 20, 2025, represents a competitive award with no set-aside designation and an ultimate completion date of August 21, 2025. The contract will be performed at AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania. Droxidopa is a neurological medication used to treat orthostatic hypotension, indicating this procurement supports military and federal healthcare system pharmaceutical needs. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement extending through December 2026. This comprehensive global pharmaceutical support vehicle enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contract portfolio demonstrates its significant role as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through competitively awarded contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.9k | 8/20/25 |